Success Metrics

Clinical Success Rate
97.6%

Based on 40 completed trials

Completion Rate
98%(40/41)
Active Trials
4(8%)
Results Posted
5%(2 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_1
1
2%
Ph not_applicable
8
16%
Ph phase_2
7
14%
Ph phase_3
16
32%
Ph phase_4
17
34%

Phase Distribution

1

Early Stage

7

Mid Stage

33

Late Stage

Phase Distribution49 total trials
Phase 1Safety & dosage
1(2.0%)
Phase 2Efficacy & side effects
7(14.3%)
Phase 3Large-scale testing
16(32.7%)
Phase 4Post-market surveillance
17(34.7%)
N/ANon-phased studies
8(16.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

97.6%

40 of 41 finished

Non-Completion Rate

2.4%

1 ended early

Currently Active

4

trials recruiting

Total Trials

50

all time

Status Distribution
Active(5)
Completed(40)
Terminated(1)
Other(4)

Detailed Status

Completed40
unknown4
Active, not recruiting3
Not yet recruiting1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
50
Active
4
Success Rate
97.6%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (2.0%)
Phase 27 (14.3%)
Phase 316 (32.7%)
Phase 417 (34.7%)
N/A8 (16.3%)

Trials by Status

unknown48%
active_not_recruiting36%
completed4080%
not_yet_recruiting12%
recruiting12%
terminated12%

Recent Activity

Clinical Trials (50)

Showing 20 of 50 trialsScroll for more
NCT07246525Phase 4

Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission

Not Yet Recruiting
NCT04009343Phase 2

Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials

Active Not Recruiting
NCT06083688Phase 4

Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi

Active Not Recruiting
NCT06516042Phase 3

Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

Active Not Recruiting
NCT04487145Phase 4

Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy

Completed
NCT06347471Phase 4

The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy

Recruiting
NCT04816461Phase 4

Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates

Completed
NCT03640403Phase 3

Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in Tanzania

Completed
NCT04864444Not Applicable

Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

Completed
NCT00852371Phase 3

Intermittent Preventive Treatment of Malaria in Schoolchildren

Completed
NCT05323721Phase 4

Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda

Unknown
NCT05980156Phase 4

Comparing Chemoprevention Drugs for School-based Malaria Control

Completed
NCT05874869Not Applicable

Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania

Completed
NCT01640587Not Applicable

Compare the Effectiveness Between Existing Treatment and New Treatment

Terminated
NCT05244954Phase 4

Comparing Chemoprevention Approaches for School-based Malaria Control

Completed
NCT03208179Phase 3

Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa

Completed
NCT04609098Phase 2

Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)

Completed
NCT01054248Phase 3

Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy

Completed
NCT04844905Phase 3

Adjunctive Ivermectin Mass Drug Administration for Malaria Control

Unknown
NCT03009526Phase 3

Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi

Completed

Drug Details

Intervention Type
DRUG
Total Trials
50